Vir Biotechnology (VIR) Sales of Property, Plant and Equipment (2020 - 2025)

Vir Biotechnology (VIR) Sales of Property, Plant and Equipment (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Vir Biotechnology 1.31 Bn 1.31 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -110,000.00
Dec 31, 2025 -110,000.00
Sep 30, 2025 37,000.00
Sep 30, 2025 37,000.00
Jun 30, 2025 45,000.00
Jun 30, 2025 45,000.00
Mar 31, 2025 281,000.00
Mar 31, 2025 281,000.00
Dec 31, 2024 2.46 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 5,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 379,000.00
Jun 30, 2024 379,000.00
Mar 31, 2024 533,000.00
Mar 31, 2024 533,000.00
Dec 31, 2022 -22,000.00
Dec 31, 2022 -22,000.00
Sep 30, 2022 11,000.00
Sep 30, 2022 11,000.00